What is a common reason for choosing meloxicam over other NSAIDs?

Choosing meloxicam over other NSAIDs is often based on its more favorable safety profile. Meloxicam is a selective COX-2 inhibitor, which means it specifically targets the cyclooxygenase-2 enzyme involved in inflammation and pain, while sparing cyclooxygenase-1, which protects the gastrointestinal lining. This selectivity can lead to a reduced risk of gastrointestinal side effects, such as ulcers and bleeding, which are common concerns with traditional non-selective NSAIDs.

Moreover, meloxicam is typically dosed once daily due to its longer half-life, leading to better patient compliance compared to NSAIDs that require multiple doses throughout the day. This dosing convenience combined with a generally better safety profile makes meloxicam a preferred choice for patients needing long-term management of conditions like arthritis. While cost-effectiveness and efficacy are important considerations, the particular emphasis on safety, especially in populations at risk for NSAID-related complications, highlights meloxicam's advantage in clinical settings.